Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(b) On July 9, 2012, Robert C. Gay, Ph.D. provided notice of his
resignation from the Board of Directors (the "Board") of Merrimack
Pharmaceuticals, Inc. (the "Company"), effective as of July 12, 2012.
(d) On July 12, 2012, the Board elected James H. Quigley as a director of
the Company to fill the vacancy created by the resignation of Dr. Gay.
Mr. Quigley was also elected to serve on the Audit Committee of the Board.
Add
MACK to Portfolio
Set Alert
Email to a
Friend